For Release: September 9, 2024, 8:00am ET
Contact: Victoria Warren, Dana-Farber Cancer Institute
Victoria_Warren@dfci.harvard.edu 617-939-5531
Barcelona - The European Society for Medical Oncology (ESMO) recognized Ann Partridge, MD, MPH, of Dana-Farber Cancer Institute, as a recipient of the 2024 ESMO Award: Addressing the Unintended Consequences of Cancer Care. The prestigious international award recognizes her work and commitment to the field of breast cancer, which has led to significant advancements in understanding breast cancer and caring for those who develop the disease around the world.
Partridge is the founder and director of the Program for Young Adults with Breast Cancer, director of the Adult Survivorship Program, and the vice chair of medical oncology at Dana-Farber. She holds the Eric P. Winer, MD, chair in breast cancer research.
Her clinical research focuses on improving the care and outcomes of patients with breast cancer, with an emphasis on treatment, survivorship, and psychosocial issues.
The esteemed ESMO Award was established in 1985 to recognize outstanding contributions to the development of medical oncology by promoting it as a specialty within the European and international community.
The 2024 ESMO Award will be presented to Partridge at the ESMO 2024 Opening Session on September 13, 2024, in Barcelona, Spain.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.
We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 5 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.